Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Dr. Marjorie Patricia

Pulmonary Medicine
National Jewish Health
1400 Jackson St, 
Denver, CO 
Offers Telehealth
25 Years of Experience
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
National Jewish Health
1400 Jackson St, 
Denver, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marjorie Patricia is a Pulmonary Medicine provider in Denver, Colorado. Dr. Patricia has been practicing medicine for over 25 years and is rated as an Experienced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Systemic Sclerosis (SSc), and Cerebral Hypoxia.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has participated in 2 clinical trials in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Graduate Institution
Johns Hopkins University School Of Medicine, 2001
Residency
Johns Hopkins University
Specialties
Pulmonary Medicine
Licenses
Critical Care Medicine in CO
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
University of Pittsburgh Medical Center
Hospital Affiliations
Platte Valley Hospital
Saint Joseph Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

National Jewish Health
1400 Jackson St, Denver, CO 80206
Other Locations
Intermountain Health Saint Joseph Hospital
1375 E 19th Ave, Denver, CO 80218

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

5 Total Publications

Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease.
Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease.
Journal: American journal of respiratory and critical care medicine
Published: June 13, 2023
Similar Doctors
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. John F. Wade
Pulmonary Medicine | Intensive Care Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. John F. Wade
Pulmonary Medicine | Intensive Care Medicine

Poudre Valley Medical Group LLC

100 Cook St, Suite 400, 
Denver, CO 
 (1.5 miles away)
720-516-9160
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Wade is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Denver, Colorado. Dr. Wade is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Bronchogenic Cyst, and Advanced Bronchoscopy. Dr. Wade is currently accepting new patients.

David B. Badesch
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. David B. Badesch
Pulmonary Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. David B. Badesch
Pulmonary Medicine

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (5.3 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Badesch is a Pulmonary Medicine provider in Aurora, Colorado. Dr. Badesch is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Acute Interstitial Pneumonia, Lung Transplant, and Myringotomy. Dr. Badesch is currently accepting new patients.

Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Samuel C. Berngard
Pulmonary Medicine
Experienced in Heart Failure with Preserved Ejection Fraction (HFpEF)
Dr. Samuel C. Berngard
Pulmonary Medicine

Boulder Community Health

4820 Riverbend Rd, Suite 100, 
Boulder, CO 
 (24.6 miles away)
303-415-5399
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Samuel Berngard is a Pulmonary Medicine provider in Boulder, Colorado. Dr. Berngard is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Eosinophilic Asthma, and Pneumonia. Dr. Berngard is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patricia's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile